Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic

G Wu1, O Korsgren, J Zhang

  • 1Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden. guoshengwu@hotmail.com

Xenotransplantation
|October 6, 2000
PubMed

Insights

Depleting macrophages significantly prolonged pig islet xenograft survival in mice, suggesting targeting macrophages is a promising strategy for xenotransplantation. Natural killer cells played a minor role.

Area of Science:

  • Transplantation Biology
  • Immunology
  • Xenotransplantation Research

Background:

  • Islet xenotransplantation offers a potential solution for diabetes.
  • Understanding immune rejection mechanisms is crucial for xenograft survival.

Purpose of the Study:

  • To investigate the impact of macrophage and natural killer (NK) cell depletion on pig islet xenograft rejection in a mouse model.
  • To evaluate the efficacy of targeting specific immune cells in preventing xenograft failure.

Main Methods:

  • Pig islets were transplanted into streptozotocin-induced diabetic C57BL/6 mice.
  • Macrophages were depleted using liposome-encapsulated dichloromethylene diphosphonate (Lip-Cl2MDP).
  • NK cells were depleted using anti-NK 1.1 monoclonal antibody (mAb).
  • Graft survival was monitored by blood glucose levels.

Main Results:

  • Macrophage depletion alone (Lip-Cl2MDP) significantly extended graft survival to 22 days (P<0.01).
  • Combined depletion of macrophages and NK cells resulted in prolonged survival up to 26 days (P<0.01), with two grafts functioning at 30 days.
  • Reduced macrophage infiltration was observed in xenografts following Lip-Cl2MDP treatment.

Conclusions:

  • Targeting macrophages represents a viable strategy to enhance islet xenograft survival.
  • While NK cells may play a role, their depletion appears less critical than macrophage depletion for xenograft success in this model.

Related Concept Videos